# üî¨ Pegfilgrastim Path Analysis Report

*Generated: 2025-12-07 14:00:25*

## 1. Drug Profile

| Property | Value |
|----------|-------|
| **Drug ID** | DB00019 |
| **Drug Name** | Pegfilgrastim |
| **Type** | drug |

## 2. Path Statistics

| Metric | Value |
|--------|-------|
| **Total Paths** | 100 |
| **Unique Diseases** | 46 |
| **Mean Attention** | 0.6104 |
| **Std Attention** | 0.0791 |
| **Min Attention** | 0.4736 |
| **Max Attention** | 0.7462 |

### Paths by Hop Count

| Hops | Count |
|------|-------|
| 2 | 400 |
| 3 | 400 |
| 4 | 400 |
| 5 | 400 |

## 3. Path Type Summary

| Path Type | Count | Description |
|-----------|-------|-------------|
| Drug Similarity | 100 | Paths through similar drugs |
| Protein Target | 0 | Paths through protein targets |
| Pathway | 0 | Paths through biological pathways |
| Biological Process | 0 | Paths through biological processes |
| Other | 0 | Other connection types |

### Key Similar Drugs

| Similar Drug | Max Attention | # Diseases |
|--------------|---------------|------------|
| Vinorelbine | 0.8802 | 28 |
| Peginterferon beta-1a | 0.8636 | 2 |
| Peginterferon alfa-2a | 0.8332 | 6 |
| Topotecan | 0.8298 | 32 |
| Vindesine | 0.8238 | 8 |
| Cyclophosphamide | 0.8131 | 4 |
| Pegaspargase | 0.8079 | 2 |
| Vinblastine | 0.7994 | 18 |

## 4. Top 20 Paths (by Combined Score)

### Path #1: obsolete rare pulmonary disease

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.550)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7149 |
| Combined Score | 0.5055 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with obsolete rare pulmonary disease. This suggests shared therapeutic mechanisms.

---

### Path #2: obsolete rare pulmonary disease

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.550)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7149 |
| Combined Score | 0.5055 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with obsolete rare pulmonary disease. This suggests shared therapeutic mechanisms.

---

### Path #3: liver failure

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.547)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7136 |
| Combined Score | 0.5046 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with liver failure. This suggests shared therapeutic mechanisms.

---

### Path #4: liver failure

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.547)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7136 |
| Combined Score | 0.5046 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with liver failure. This suggests shared therapeutic mechanisms.

---

### Path #5: interstitial lung disease

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.540)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7102 |
| Combined Score | 0.5022 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with interstitial lung disease. This suggests shared therapeutic mechanisms.

---

### Path #6: interstitial lung disease

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.540)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7102 |
| Combined Score | 0.5022 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with interstitial lung disease. This suggests shared therapeutic mechanisms.

---

### Path #7: endometrium neoplasm

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.539)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7097 |
| Combined Score | 0.5019 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with endometrium neoplasm. This suggests shared therapeutic mechanisms.

---

### Path #8: endometrium neoplasm

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.539)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7097 |
| Combined Score | 0.5019 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with endometrium neoplasm. This suggests shared therapeutic mechanisms.

---

### Path #9: intestinal obstruction

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.538)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7093 |
| Combined Score | 0.5016 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with intestinal obstruction. This suggests shared therapeutic mechanisms.

---

### Path #10: intestinal obstruction

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.538)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7093 |
| Combined Score | 0.5016 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with intestinal obstruction. This suggests shared therapeutic mechanisms.

---

### Path #11: ileus

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.538)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7090 |
| Combined Score | 0.5013 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with ileus. This suggests shared therapeutic mechanisms.

---

### Path #12: ileus

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.538)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7090 |
| Combined Score | 0.5013 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with ileus. This suggests shared therapeutic mechanisms.

---

### Path #13: lung disease

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.538)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7089 |
| Combined Score | 0.5013 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with lung disease. This suggests shared therapeutic mechanisms.

---

### Path #14: lung disease

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.538)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7089 |
| Combined Score | 0.5013 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with lung disease. This suggests shared therapeutic mechanisms.

---

### Path #15: leukopenia

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.533)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7067 |
| Combined Score | 0.4997 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with leukopenia. This suggests shared therapeutic mechanisms.

---

### Path #16: leukopenia

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.533)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.7067 |
| Combined Score | 0.4997 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with leukopenia. This suggests shared therapeutic mechanisms.

---

### Path #17: infectious disease

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.516)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6982 |
| Combined Score | 0.4937 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with infectious disease. This suggests shared therapeutic mechanisms.

---

### Path #18: infectious disease

**Path:**
```
[Pegfilgrastim] --(0.880)--> [Vinorelbine] --(0.516)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6982 |
| Combined Score | 0.4937 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Vinorelbine, which is associated with infectious disease. This suggests shared therapeutic mechanisms.

---

### Path #19: relapsing-remitting multiple sclerosis

**Path:**
```
[Pegfilgrastim] --(0.864)--> [Peginterferon beta-1a] --(0.530)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6966 |
| Combined Score | 0.4926 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Peginterferon beta-1a, which is associated with relapsing-remitting multiple sclerosis. This suggests shared therapeutic mechanisms.

---

### Path #20: relapsing-remitting multiple sclerosis

**Path:**
```
[Pegfilgrastim] --(0.864)--> [Peginterferon beta-1a] --(0.530)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6966 |
| Combined Score | 0.4926 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Pegfilgrastim is similar to Peginterferon beta-1a, which is associated with relapsing-remitting multiple sclerosis. This suggests shared therapeutic mechanisms.

---

## 5. Interpretation Guidelines

### Attention Score Scale

| Score Range | Confidence | Interpretation |
|-------------|------------|----------------|
| ‚â• 0.70 | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High | Strong biological relationship |
| 0.60 - 0.70 | ‚≠ê‚≠ê‚≠ê‚≠ê High | Good evidence for connection |
| 0.50 - 0.60 | ‚≠ê‚≠ê‚≠ê Medium | Moderate support |
| 0.40 - 0.50 | ‚≠ê‚≠ê Low | Weak connection |
| < 0.40 | ‚≠ê Very Low | Speculative |

### How to Use This Report

1. **Prioritize high-scoring paths**: Focus on paths with combined scores > 0.45
2. **Validate intermediate nodes**: Cross-reference proteins/drugs with literature
3. **Consider path length**: Shorter paths (2-3 hops) are generally more reliable
4. **Check for known associations**: Some paths may represent known indications

---

*Report generated by TxGNN Path Analysis Pipeline*